Impressive results for Anito-Cel new BCMA-targeted CART for #myeloma after median 4 prior lines of Rx. Proud that the #Karmanos Cancer Institute’s Dr Abhinav Deol was a co-investigator. This CART now in Phase 3 trial
20
1
3
0